Voices
Giuseppe Procopio: Positive Report by BonEnza Study Assessing Bone Health in Prostate Cancer
Photo: ilgiorno.it

Giuseppe Procopio: Positive Report by BonEnza Study Assessing Bone Health in Prostate Cancer

Giuseppe Procopio, Director of the Genitourinary Cancer Unit at National Cancer Institute Foundation, IRCCS, shared a post on X:

“Additional positive report by BONENZA trial lead by Alfredo Berruti.”

Title: Multiparametric assessment of bone health in metastatic hormone-sensitive prostate cancer patients receiving androgen deprivation + enzalutamide ± zoledronic acid (BonEnza study)

Authors: Caramella, A Dalla Volta, F Valcamonico, M Bergamini, M Buffoni, A Zivi, G Procopio, P Sepe, N Di Meo, S Foti, S Zamboni, C Messina, A Rizzi, E Lucchini, M Ravanelli, M Zamparini, F Zacchi, M Laganà, D Cosentini, R Bresciani, N Suardi, D Farina, A Berruti.

Read the article

Giuseppe Procopio

Other articles featuring Giuseppe Procopio on OncoDaily.

A Berruti A Dalla Volta A Rizzi A Zivi C Messina cancer Caramella D Cosentini D Farina E Lucchini F Valcamonico F Zacchi G. Procopio Giuseppe Procopio M Bergamini M Buffoni M Laganà M Ravanelli M. Zamparini N Di Meo N Suardi OncoDaily Oncology P Sepe prostate cancer R Bresciani S Foti S Zamboni